Expert Review of Neurotherapeutics, Volume 19, Issue 7 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Neurotherapeutics, Volume 19, Issue 7 (2019)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Volume 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?
Francesco Panza, Madia Lozupone, Mark Watling & Bruno Pietro Imbimbo
Pages: 599-602
Published online: 27 May 2019
First Page PreviewforDo BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease? | Full Text | References | PDF (487.3 KB) | EPUB
  • 2905 Views
  • 27 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
CVT-301 for the treatment of Parkinson’s disease
Danielle S. Shpiner, Sagari Bette, Daniel G. Di Luca & Jason Margolesky
Pages: 603-611
Published online: 28 May 2019
AbstractforCVT-301 for the treatment of Parkinson’s disease | Full Text | References | PDF (710.2 KB) | EPUB
  • 300 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

Review
Cognitive and behavioral assessment in Parkinson’s disease
Saul Martinez-Horta, Andrea Horta-Barba & Jaime Kulisevsky
Pages: 613-622
Published online: 17 Jun 2019
AbstractforCognitive and behavioral assessment in Parkinson’s disease | Full Text | References | PDF (824.1 KB) | EPUB
  • 397 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors
Yung-Chih Kuo & Rajendiran Rajesh
Pages: 623-652
Published online: 29 May 2019
AbstractforChallenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors | Full Text | References | PDF (3.5 MB) | EPUB
  • 424 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
The overlap between epilepsy and Alzheimer’s disease and the consequences for treatment
Graham Powell, Besa Ziso & AJ Larner
Pages: 653-661
Published online: 26 Jun 2019
AbstractforThe overlap between epilepsy and Alzheimer’s disease and the consequences for treatment | Full Text | References | PDF (716 KB) | EPUB
  • 1294 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target
Candice D. Carpenter, Iyad Alnahhas, Javier Gonzalez, Pierre Giglio & Vinay K. Puduvalli
Pages: 663-677
Published online: 27 May 2019
AbstractforChanging paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target | Full Text | References | PDF (1.1 MB) | EPUB
  • 203 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Intracerebral hemorrhage: an update on diagnosis and treatment
Isabel C. Hostettler, David J. Seiffge & David J. Werring
Pages: 679-694
Published online: 12 Jun 2019
AbstractforIntracerebral hemorrhage: an update on diagnosis and treatment | Full Text | References | PDF (1.5 MB) | EPUB
  • 4060 Views
  • 144 CrossRef citations
  • 0Altmetric
Review
Assessing the risk of multiple sclerosis disease-modifying therapies
Xavier Ayrignac, Philippe-Antoine Bilodeau, Alexandre Prat, Marc Girard, Pierre Labauge, Jacques Le Lorier, Catherine Larochelle & Pierre Duquette
Pages: 695-706
Published online: 26 Jun 2019
AbstractforAssessing the risk of multiple sclerosis disease-modifying therapies | Full Text | References | PDF (992.3 KB) | EPUB
  • 522 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD
Fatuma Nageye & Samuele Cortese
Pages: 707-717
Published online: 26 Jun 2019
AbstractforBeyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD | Full Text | References | PDF (823.8 KB) | EPUB
  • 1002 Views
  • 18 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
P. Moondra et al.
Review Article | Published online: 9 Jul 2024
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease
James E. Eaton et al.
Editorial | Published online: 9 Jul 2024
Free Access
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias
Marie Beaudin et al.
Review Article | Published online: 9 Jul 2024
Risk of suicide and suicide-related events in subjects treated with antiseizure medications
Boulenouar Mesraoua et al.
Review Article | Published online: 8 Jul 2024
View all latest articles